Opinion|Videos|August 30, 2024

Strategies to Manage Type 2 Inflammation in Respiratory Diseases

A key opinion leader explores therapeutic approaches targeting inflammation to alleviate symptoms in COPD and asthma patients.

  • How do these markers influence the treatment regimen for patients with asthma or COPD?
  • How do comorbidities affect the management of type 2 inflammation in asthma and COPD?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo